Clinical Trial Update: Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized, blinded crossover trial comparing loperamide to placebo for ileostomy output in patients with rectal cancer, ulcerative colitis, or short …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer
• Short Bowel Syndrome
• Ulcerative Colitis

Drugs mentioned

• Loperamide (loperamide)

Snippet

Sponsor: Odense University Hospital | Conditions: Rectal Cancer, Ulcerative Colitis | Phase 3 | Status: TERMINATED